Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anti‐mitotic agent SB‐216 overcomes taxane resistance in castration‐resistant prostate cancer and exhibits anti‐tumour efficacy in pancreatic cancer

British Journal of Pharmacology(2025)10.1111/bph.70294Source: DataRank Database

Anti‐mitotic agent SB‐216 overcomes taxane resistance in castration‐resistant prostate cancer and exhibits anti‐tumour efficacy in pancreatic cancer is a research paper published in British Journal of Pharmacology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.78)OA: bronzeTopics (49)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Chun Cai ORCID,Shanshan Deng ORCID,Yang Xie ORCID,Satyanarayana Pochampally ORCID,David P. Hamilton ORCID

Live enrichment

PubMed:41408705 OpenAlex:https://openalex.org/W4417447749

National Institutes of Health

Grant: CA148706

FWCI

0.78

Citation Percentile

0.8%

Citation Trend

2026

bronzeLicense: http://doi.wiley.com/10.1002/tdm_license_1.1

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.70294

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.70294

publisherhttps://bpspubs.onlinelibrary.wiley.com/doi/pdf/10.1111/bph.70294

publisherhttps://bpspubs.onlinelibrary.wiley.com/doi/full-xml/10.1111/bph.70294

journalhttps://doi.org/10.1111/bph.70294

Fields of Study

Prostate Cancer Treatment and ResearchMicrotubule and mitosis dynamicsCancer Treatment and PharmacologyMaleHumansAnimalsProstatic Neoplasms, Castration-ResistantDrug Resistance, NeoplasmPancreatic NeoplasmsMiceCell Line, TumorXenograft Model Antitumor AssaysAntimitotic AgentsMice, NudeTaxoidsAntineoplastic AgentsCell ProliferationBridged-Ring CompoundsMitosis

MeSH Terms

AnimalsAntineoplastic AgentsBridged-Ring CompoundsHumansMaleMice, NudeMitosisPancreatic NeoplasmsDrug Resistance, NeoplasmXenograft Model Antitumor AssaysTaxoidsCell Line, TumorCell ProliferationAntimitotic AgentsMiceProstatic Neoplasms, Castration-Resistant

Keywords

Pancreatic cancerProstate cancerTaxaneCancerPaclitaxelAcquired resistanceAdenocarcinomaCell proliferationChemotherapyPancreatic Ductal AdenocarcinomaOrganoidsPaclitaxel ResistanceCastration‐resistant Prostate CancerTubulin Colchicine‐binding Site Inhibitors